Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
63.68 USD | +0.94% |
|
+8.80% | +15.49% |
26/06 | HC Wainwright Adjusts ANI Pharmaceuticals Price Target to $94 From $87, Maintains Buy Rating | MT |
24/06 | Top Midday Gainers | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.49% | 123.59Cr | |
+55.32% | 82TCr | |
+44.05% | 64TCr | |
-6.75% | 35TCr | |
+13.56% | 31TCr | |
+10.68% | 30TCr | |
+16.57% | 24TCr | |
+13.31% | 22TCr | |
+8.48% | 17TCr | |
-2.81% | 16TCr |
- Stock Market
- Equities
- ANIP Stock
- News ANI Pharmaceuticals, Inc.
- ANI Pharmaceuticals to Acquire Alimera Sciences in $381 Million Deal